Part 4 Capital Fees for Applications for Variations of Authorizations, Licences and RegistrationsF1
United Kingdom Repealed
- 35Marketing authorizations
- 35AVariations to the terms of marketing authorizations
- 36Variation of marketing authorizations
- 37Reclassification of marketing authorizations
- 38Variation of marketing authorization: national homoeopathic products
- 39Variation of parallel import licence
- 40Manufacturer's authorisations and licences
- 41Variation of manufacturer's authorisations and licences
- 42Wholesale dealer's licences
- 43Variation of wholesale dealer's licence
- 44Clinical trial authorisations
- 45Traditional herbal registrations
- 46Identical variations
- 46AReduced fees for Type IB and Type II Applications, Minor Variation (Type IB) Group Applications and a Major Variation (Type II) Group Applications
- 47Complex Variation Applications
- 47AReduced Fees for identical Type II Complex Applications, Extended Type II Complex Variation Applications, Major Variation (Type II) Complex Group Applications and Major Variation (Type II) Extended Complex Group Applications
- 48Multiple reclassification variation applications
Annotations
Textual amendments
- F1
Regulations revoked (1.4.2010) by The Medicines (Products for Human Use) (Fees) Regulations 2010 (S.I. 2010/551), regs. 1, 52(1) (with reg. 52(2)-(4))